About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Neutropenia in Sirolimus Treated Patients of Lymphatic Malformation: A Case Series

viagra prodej inzerce

viagra wiki read here
Lama Altawil1, Nada Fouda Neel2, Alanoud Alhedyani1, Mohammad Badran3, Riyadh Alokaili3, Saad AlAjlan4
Student, College of Medicine, 1King Saud University and 2Alfaisal University, Riyadh, Saudi Arabia; Departments of 3Radiology and 4Dermatology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Corresponding Author:
Dr. Saad Alajlan
Email: salajlan@kfshrc.edu.sa 
Received: 20-JAN-2017 Accepted: 04-APR-2017 Published Online: 05-MAY-2017
DOI: http://dx.doi.org/10.17659/01.2017.0047
Abstract
Background: Lymphatic malformations (LMs) are rare benign tumors that are at risk of various complications due to their progressive nature and critical locations. Considering the morbidity and mortality of such lesions, different therapeutic methods  proposed are surgical excision, sclerotherapy, laser, aspiration, radiotherapy, and most recently sirolimus. Case Reports: We reviewed 3 cases with lymphatic malformation at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Initially placed on various treatment sessions of surgical intervention, sclerotherapy or even both prior to sirolimus, minimal improvement was noted. Sirolimus initiation was associated with significant clinical improvement. However, sirolimus was associated with neutropenia, which was successfully managed by G-CSF. Conclusion: Sirolimus can cause bone marrow suppression due to cumulative effect.
Keywords : Bone Marrow, Lymphatic Abnormalities, Neoplasms, Neutropenia, Sirolimus.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share